Tools for the Individualized Therapy of Teicoplanin for Neonates and Children

The aim of this study was to develop a population pharmacokinetic (PK) model for teicoplanin across childhood age ranges to be used as Bayesian prior information in the software constructed for individualized therapy. We developed a nonparametric population model fitted to PK data from neonates, inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Martín, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., Paulus, S., López-Herce, J., Hope, W. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610524/
https://www.ncbi.nlm.nih.gov/pubmed/28760897
http://dx.doi.org/10.1128/AAC.00707-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610524/
https://www.ncbi.nlm.nih.gov/pubmed/28760897
http://dx.doi.org/10.1128/AAC.00707-17

Ejemplares similares